SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint

Authors

Coyle PV, Chemaitelly H, Kacem MABH, Molawi NHAA, Kahlout RAE, Gilliani I, Younes N, Kanaani ZA, Khal AA, Kuwari EA, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HFA, Nasrallah GK, Yassine HM, Kuwari MGA, Romaihi HEA, Al-Thani MH, Bertollini R, Abu-Raddad LJ

Journal

medRxiv

Publication year

2021

Suggested citation

Coyle PV, Chemaitelly H, Kacem MABH, Molawi NHAA, Kahlout RAE, Gilliani I, Younes N, Kanaani ZA, Khal AA, Kuwari EA, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HFA, Nasrallah GK, Yassine HM, Kuwari MGA, Romaihi HEA, Al-Thani MH, Bertollini R, Abu-Raddad LJ. SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint. medRxiv. 2021.

DOI

10.1101/2021.01.05.21249247

Header sites

Search form

Main menu

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint

Nav